BRUSSELS (Reuters) - Brussels has persuaded Washington to ease restrictions on exports of materials needed by German biotech firm CureVac to make its experimental COVID-19 vaccine, three people familiar with the matter said.
EU officials said the decision will enable CureVac to produce vaccines until August and is part of a months-long effort by Brussels to get the White House to drop or ease some of its export curbs, following the election of U.S. President Joe Biden.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!